Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375530 · ClinicalTrials.gov registry record
Screening Volunteers for Clinical Trials
A clinical trial of Screening, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 4
- Study locations
NCT01375530 is a study of Screening that is actively recruiting participants, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 4,000 participants, above the 1,132-participant average among 3 other Screening trials with a reported enrollment target (253% higher). The trial reports 4 study locations across 3 states.
The verdict
NCT01375530, a study of Screening, is actively recruiting participants, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Background: \- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work. Objectives: \- To screen healthy volunteers for clinical trials at the NIAID VRC. Eligibility: \- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies. Design: * Screening for healthy volunteers to participate in clinical trials is an ongoing process. * Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed. * Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status. * Volunteers will not receive any investigational product in this screening protocol.
Conditions Studied
Study Locations (4)
Maryland
- Univ of MD School of Medicine Center for Vaccine Development & Global Health - Baltimore
- National Institutes of Health Clinical Center - Bethesda
Georgia
- Emory University - Atlanta
Pennsylvania
- University of Pennsylvania-UPenn - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2011-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375530
The ClinicalTrials.gov registry entry for NCT01375530 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,132-participant average among 3 other Screening trials with a reported enrollment target (253% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Screening appearing as the primary indexed condition, and to 0 interventions.
NCT01375530 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Maryland, Georgia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01375530 about?
NCT01375530 is a clinical study titled "Screening Volunteers for Clinical Trials". Background: \- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical tria...
What is the current status of trial NCT01375530?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2011-08-16.
What conditions does trial NCT01375530 study?
This clinical trial studies the following conditions: Screening.
Who is sponsoring clinical trial NCT01375530?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01375530 being conducted?
This trial has 4 study locations across Georgia, Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
RECRUITING · NA
-
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
RECRUITING · NA
-
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.